Senators want to review home infusion pricing with CMS

 - 
Thursday, September 24, 2015

Senators want to review home infusion pricing with CMS

WASHINGTON – More than a dozen senators have written a letter to Senate Majority Leader Mitch McConnell and Minority Leader Harry Reid asking for time to review S. 275, the Medicare Home Infusion Site of Care Act, with CMS. “We urge that the average sales price pricing provisions from H.R. 6 or H.R. 2570 not be included in any legislation that does not recognize the services component of care that is included in S. 275,” stated the letter. The House of Representatives passed H.R. 6 and H.R. 2570, changing Medicare reimbursement of Part B DME infusion drugs to an ASP methodology. The senators argue, however, that without the inclusion of payment for required professional services patients are at risk of losing access to care. The 13 signers of the letter include Sen. Johnny Isakson, R-Ga., who sponsored S. 275.